A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD)

Name: A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD)
Published: 2023
License: Public Domain

Hoffmann-La Roche · 2023

ClinicalTrials.gov · Datasets · License: Public Domain · 2023

Open Source ↗

duchenne-muscular-dystrophy pediatric

duchenne muscular dystrophy, dmd, duchenne, dystrophin, gene-delivery, pediatric, interventional, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

A Gene Delivery Study to Evaluate the Safety and Expression of Delandistrogene Moxeparvovec in Participants Under the Age of Four With Duchenne Muscular Dystrophy (DMD)

Related documents